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Background: Bifidobacterium species, including Bifidobacterium pseudocatenulatum, are among the dominant
microbial populations of the human gastrointestinal tract. They are also major components of many commercial
probiotic products. Resident and transient bifidobacteria are thought to have several beneficial health effects.
However, our knowledge of how these bacteria interact and communicate with host cells remains poor. This
knowledge is essential for scientific support of their purported health benefits and their rational inclusion in
functional foods.
Results: This work describes the draft genome sequence of Bifidobacterium pseudocatenulatum IPLA 36007,
a strain isolated as dominant from the feces of a healthy human. Besides several properties of probiosis, IPLA
36007 exhibited the capability of releasing aglycones from soy isoflavone glycosides. The genome contains 1,851
predicted genes, including 54 genes for tRNAs and fie copies of unique 16S, 23S and 5S rRNA genes. As key
attributes of the IPLA 36007 genome we can mention the presence of a lysogenic phage, a cluster encoding type
IV fimbriae, and a locus encoding a clustered, regularly interspaced, short, palindromic repeat (CRISPR)-Cas system.
Four open reading frames (orfs) encoding β-glucosidases belonging to the glycosyl hydrolase family 3, which may
act on isoflavone glycosides, were encountered. Additionally, one gene was found to code for a glycosyl hydrolase
of family 1 that might also have β-glucosidase activity.
Conclusion: The availability of the B. pseudocatenulatum IPLA 36007 genome should allow the enzyme system
involved in the release of soy isoflavone aglycones from isoflavone glycosides, and the molecular mechanisms
underlying the strain’s probiotic properties, to be more easily understood.Introduction
Bifidobacterium species are majority bacteria among those
inhabiting the gastrointestinal tract (GIT) of animals and
humans. They play important roles in maintaining human
health via the digestion of foods, production of essential
vitamins, and metabolization of endogenous and exogen-
ous compounds, as well as by preventing the colonization
and/or overgrowth of pathogens in the GIT [1]. Molecular
analyses have shown that members of the Bifidobacterium* Correspondence: baltasar.mayo@ipla.csic.es
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unless otherwise stated.catenulatum group (which includes B. catenulatum and
B. pseudocatenulatum) are abundant in fecal samples from
adult humans [2,3]. B. pseudocatenulatum strains have a
number of probiotic properties, such as the possession of
antinutrient-degrading enzymes [4], the ability to bind
mutagenic aromatic amines [5], and the capacity to reduce
cholesterol levels [6]. However, compared to other bifido-
bacterial species, the genome of B. pseudocatenulatum has
been very little explored. The Genomes Online Database
(GOLD) (http://www.genomesonline.org) only contains
the draft sequence of a single strain, B. pseudocatenulatum
DSM 20438 (Gi02660), plus recently released incomplete
sequences of five other strains (D2CA; TSDC19.1-1.1;
TSDC19.1-1.2; TSDC19.1-1.3; and TSDC17.2-1.1). Se-
quence analysis of additional B. pseudocatenulatum strainsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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variation of this species, and supply information on
the genetics that underlay strain-specific capabilities.
Recently, B. pseudocatenulatum has been used as a clon-
ing host for the expression of natural [7] and synthetic [8]
genes. Genomic analyses of strains of this species might
allow the confident use of this bacterium in other biotech-
nological applications.
Bifidobacterial strains have been shown to be involved in
the conversion of isoflavone glycosides into aglycones
[9,10], a key step in making isoflavones bioavailable and
harnessing their estrogenic activity [11]. Indeed, the ge-
nomes of sequenced bifidobacteria show an impressive
array of genes coding for glycosyl hydrolases, including β-
glucosidases, which are thought to be involved in the re-
lease of aglycones from dietary polyphenols such as soy
isoflavones [12,13]. However, the enzyme(s) involved in the
hydrolysis of soy isoflavone glycosides remain(s) mostly un-
known. So far, a β-glucosidase from Bifidobacterium ani-
malis subsp. lactis has been shown to possess aglycone-
releasing activity from isoflavones by cloning and expres-
sion of its encoding gene in Bifidobacterium bifidum [14].
The present work provides a draft genome sequence
for B. pseudocatenulatum IPLA 36007, an intestinal
human strain able to release aglycones from the soy
isoflavone glycosides daidzin and genistin. This capability
endows it with properties of interest in terms of its use in
functional foods.
Materials and methods
Isolation and DNA preparation
B. pseudocatenulatum IPLA 36007 was isolated among
the dominant bacteria from fecal samples of a healthy hu-
man, in a study approved by The Ethic Committee of the
Asturias Principality, Spain [15]. The strain was grown an-
aerobically at 37°C in MRS medium (Merck, Darmstadt,
Germany) supplemented with 0.25% cysteine (Merck).
Genomic DNA was extracted and purified from pure cul-
tures using the GenElute™ Bacterial Genomic DNA kit
(Sigma-Aldrich, St. Louis, Miss., USA) following the manu-
facturer’s instructions for extracting DNA from Gram-
positive bacteria. The concentration and quality of the
DNA was measured using an Epoch microvolume spectro-
photometer (BioTek Instruments, Winooski, Vt., USA).
Aglycone releasing-activity from isoflavone glycosides
Strains were incubated anaerobically in a MRS basal
medium without dextrose and supplemented with 2%
cellobiose and 100 μM daidzin or ginistin (Sigma-Aldrich)
at 37°C for 24 h. One ml cultures were centrifuged and
the cells suspended in the same volume of 0.1 M sodium
acetate buffer pH 4.1. Isoflavones and derivatives were
then extracted with ethyl acetate (Sigma-Aldrich). The
organic phase was evaporated and the dried pelletsuspended in 100 μl of methanol. Five 5 μl were used
for analysis by TLC in silica gel 60 F254 plates (Merck).
Isoflavones were separated in a toluene:acetone (2:1)
solvent system, revealed by UV light at 365 nm in a
transilluminator and visualized with an ImageQuant 350
(GE Healthcare Bio-Sciences, Buckinghamshire, UK).
Genome sequencing, assembly and annotation
A genomic library of 0.5 kbp was constructed and
paired-end sequenced (approximately 155-fold coverage)
using a HiSeq 1000 System sequencer (Illumina, Inc.,
San Diego, CA, USA). Quality-filtered reads were assem-
bled in contigs using Velvet software v.1.2.10. (https://
www.ebi.ac.uk/~zerbino/velvet/). Gaps within the con-
tigs were closed by direct sequencing of amplicons ob-
tained by PCR with oligonucleotide primers designed to
anneal in the flanking regions. The genome was annotated
with the RAST annotation system (http://rast.nmpdr.org/)
and the NCBI Prokaryotic Genome Annotation Pipeline
(http://www.ncbi.nlm.nih.gov/genome/annotation_prok/).
The KEGG Pathway (http://www.genome.jp/kegg/pathway.
html), Uniprot (http://www.uniprot.org) and COG (http://
www.ncbi.nlm.nih.gov/COG) databases were consulted for
description of specific genes and proteins. If required,
DNA and deduced protein sequences were individually
subjected to BLAST analysis (http://blast.ncbi.nlm.nih.gov/
Blast.cgi). Multi-blast protein comparisons were performed
with the CLC Bioinformatics Database software package
(CLC bio, Aarhus, Denmark).
Nucleotide sequence accession numbers
The results of this Whole Genome Shotgun project have
been deposited in the GenBank database under accession
number JEOD00000000. The version described in this
paper is JEOD01000000.
Results and discussion
Among a large collection of intestinal bifidobacteria
strains from human origin, B. pseudocatenulatum IPLA
36007 showed aglycone-releasing activity from isoflavone
glycosides. Figure 1 shows the conversion of daidzin into
daidzein after incubation with IPLA 36007 cells. Similar
activity was detected using genistin as a substrate, which
was transformed into genistein (data not shown). As this
strain has already shown a bunch of key properties for its
use as a probiotic, including among others good survival
under conditions simulating those of the GIT, absence of
undesirable enzyme activities and atypical antibiotic resis-
tances, and ability to bind human intestinal epithelial cells
[16], it was selected for whole genome sequencing in
order to get insights on the molecular basis of its relevant
phenotypic traits.
The general features of the B. pseudocatenulatum IPLA
36007 genome are summarized in Table 1. The draft
S1 21 S2
Figure 1 TLC chromatogram showing the conversion of daidzin
to daidzein by B. pseudocatenulatum IPLA 36007. Order: line1,
daidzin incubated with whole cells a negative Bifidobacterium longum
strain; line 2, daidzin incubated with cells of B. pseudocatenulatum IPLA
36007; lines S1 and S2, daidzin and daidzein standards, respectively.
Arrows point to the position of daidzin and daidzein.
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varying in size from 203 to 548,016 bp. According to the
NCBI Prokaryotic Genome Annotation Pipeline the gen-
ome harbors 1,851 genes, of which 1,769 are coding se-
quences (CDS) and 22 are pseudogenes. Additionally, 60
predicted RNA genes were identified, including five copies
of identical 16S, 23S and 5S rRNA genes, a non-coding
RNA molecule (ncRNA), and 54 genes coding for tRNAs.
The RAST server classified the CDS into 26 classes and
255 subsystems (sets of related functional roles).
This strain was demonstrated plasmid-free (data not
shown), and, in agreement, no plasmid-associated genes
were found. However, one integrated phage of around
43.5 kbp was recorded. The lysogenic phage region con-
sisted of 76 CDS, and included a gene encoding a
retron-type RNA-directed DNA polymerase typical of
group II introns [17]. Phage-related sequences have been
described in the genome of 22 strains of different bifido-
bacteria species, but only fragmentary information existsTable 1 Key features of the B. pseudocatenulatum IPLA 36007
Characteristic Figures
Size of the genome 2,328,179 bpa
G + C content 56.4%
Contigs 23
Open reading frames (ORFs) 1851






Glycosyl-hydrolases and glycosyl transferases >50
β-glucosidases 5
abp, base pair; ncRNA, non-coding RNA.with regard to their functionality [18]. As in other bacteria,
bifidobacterial prophages have been shown to possess
classical modular genomic organization in which the DNA
lysogeny module and the DNA packaging region are the
most highly conserved.
A cluster of nine genes capable of encoding type IV
fimbriae or pili was identified. This contained, among
others, orthologous genes for pilA, pilB, pilC, pilM, and
pilT (Figure 2). Operons encoding type IV fimbriae
have also been found in the genome of other sequenced
B. pseudocatenulatum strains, in other bifidobacterial
species, and in some environmental actinobacteria. Such
pili have been well studied in Gram-negative bacteria
such as Neisseria gonorrhoeae, Pseudomonas aeruginosa,
Pseudomonas stutzeri, Moraxella bovis and Dichelobacter
nodosus [19]. In these pathogenic bacteria, they mediate
attachment and adherence to epithelial cells, twitching
motility, gliding motility, cell agglutination, and biofilm
and fruiting body formation [19]. In addition, they act as
receptors for bacteriophages, and are required for extra-
cellular protein secretion and natural transformation [19].
The expression and functionality of the type IV fimbriae
genes in B. pseudocatenulatum IPLA 36007 has yet to be
demonstrated.
A locus encoding a CRISPR-Cas (clustered regularly
interspaced short palindromic repeats-CRISPR-associated
proteins) system was identified (Figure 3). This locus con-
tained 22 identical repeats of 33 bp (except for one repeat
carrying a single C-T transition at position five) and 21
spacers ranging from 32 to 37 bp (Figure 3B). The repeats
(5′-GTCGCTCTCCTCATGGAGAGCGTGGATTGAAA
T-3′) were preceded by eight CRISPR-associated (cas)
genes (Figure 3A). Spacers showed no significant hom-
ology to DNA sequences on databases. Gene content and
gene order analysis showed the CRISPR-Cas system of
IPLA 36007 to belong to type I-C [20]. CRISPR-Casgenome
Observations
(from 203 to 548,016 bp long)
5 rRNA operons, 54 tRNA, 1 ncRNA
Plasmid free strain
76 CDS
22 repeats, 21 spacers, 8 CDS













Figure 2 Locus of the type IV fimbriae in B. pseudocatenulatum IPLA 36007. In green, hortologous genes to those in other fimbriae/pili
clusters. In blue, hypothetical genes belonging to the cluster. In grey, flanking CDS not related to the cluster. Pale blue background boxes
indicate functionally coupled genes sharing conserved relative positions in the genome of at least four other species.
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derived from bacteriophages, plasmids and other sources.
These systems target and digest foreign DNA in an RNA-
dependent, sequence-specific manner, and are also adap-
tive, providing protection against previously encountered
exogenous elements [19]. Physiological roles for CRISPR-Figure 3 Diagram of the CRISPR-Cas locus of B. pseudocatenulatum IP
DNA. Orthologous genes are color coded following protein family relations
separate helicase and DNase activities. Either Cas5 or Cas7 possess RNase a
rhombs. In grey, bounding CDS not related to the CRISPR-Cas system. Pan
21, which harbors a single bp change) are separated by unrelated 32 to 37
genes sharing conserved relative positions in the genome of at least four ocas systems other than in defense against foreign DNA are
slowly being uncovered [21].
Bifidobacteria utilize a wide range of carbohydrates
that escape digestion in the upper parts of the intestine,
many of which are plant derived oligo- and polysaccha-
rides [22]. The genome of B. pseudocatenulatum IPLALA 36007. Panel A: The type I CRISPR–Cas systems seem to target
hips as suggested by Makarova et al. [20]. Cas3 is a large protein with
ctivity. CRISP repeats and spacers are indicated by rectangles and
el B: Twenty two identical 33 base pair (bp) repeats (except for repeat












Figure 4 Genetic organization around the putative β-glucosidase-encoding genes. Five genes encoding glycosyl hydrosilases of family 3
(A through D) and a gene encoding a gycosyl hydrolase of family 1 (E) were identified in the B. pseudocatenulatum IPLA 36007 genome.
Color code: glycosidase genes are in red; in green, genes involved in transport; in blue, genes involved in carbohydrate(s) metabolism; in brown,
genes encoding regulator proteins; in gray, genes belonging to a distinct RAST subsystem; boxes represent genes encoding tRNA and 5S rRNA
molecules. Pale blue background boxes indicate functionally coupled genes sharing conserved relative positions in the genome of at least four
other species.
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glycosyl hydrolases CDS (52 genes), including genes that
code for xylanases (4), pullulanases (3), amylomaltases
(2) α-amylase (1) and maltodextrin glucosidase (1). It
also harbors genes encoding α- (5) and β- (9) galactosi-
dases, α- (1) and β- (7) xylosidases, α- (1) and β- (4) gluco-
sidases, α-arabinofuranosidases (4), β- mannosidases (2),
and α-rhamnosidases (1). Although belonging to the gly-
cosyl hydrolase family 3, all four β-glucosidases (EC
3.2.1.21) shared very limited amino acid identity (26.2%)
(Figure 4, A through D). Multiblast analysis of the β-
glucosidases found in the IPLA 36007 genome and
those present in bifidobacterial genomes suggested
that homologous enzymes are present in bifidobacteria
strains belonging to the Bifidobacterium adolescentis
group (B. adolescentis, B. dentium, B. angulatum, B. cate-
nulatum, etc.) (amino acid identity ranging from 80 to
98%). The homology to glycosyl hydrolases from other
groups of bifidobacteria was much lower (less than 70%
amino acid identity) (Additional file 1: Figure S1). Indeed,
the similarity of the deduced β-glucosidases from IPLA
36007 to that of B. animalis subps. lactis SH5, which have
been proved to act on soy isoflavone glycosides [14], was
found to be marginal (23% amino acid identity). An
additional gene encoding a putative glycoside hydro-
lase belonging to family 1 (EC 3.2.1.23) was detected;
this might also have β-glucosidase activity (Figure 4, E).
Characterization of these genes and their encoded glycosyl
hydrolase enzymes would allow those acting on soy isofla-
vone glycosides to be identified. However, hydrolysis ofisoflavone glycosides some others glycosyl hydrolases of
those detected cannot be discarded.
The availability of the genome of the B. pseudocatenu-
latum IPLA 36007 strain should allow the enzymes
involved in the release of soy isoflavone aglycones from
isoflavone glycosides to be known. This is essential for
the rational use of IPLA 36007 as a probiotic in functional
foods. The ability of IPLA 36007 to colonize the GIT
could be exploited to deliver the aglycone-releasing activ-
ity straightway into the human intestine. Comparison of
sequences from different sequenced strains would provide
greater insights into the genetic variation within this spe-
cies. It will further allow the core genome and pangenome
of B. pseudocatenulatum to be identified, while contribut-
ing towards defining the gene set required to be competi-
tive in the human GIT.Additional file
Additional file 1: Figure S1. Multiblast analysis of putative
β-glucosidases from Bifidobacterium pseudocatenulatum IPLA 36007 to
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